Comparing two whole-body imaging systems for skin cancer screening
Part of Cancer, Skin clinical trials.
This study compares two different whole-body imaging systems that take pictures of your skin to screen for skin cancer. It looks at which system is easier and more comfortable for people at higher risk of melanoma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to be able to understand and follow instructions in German.
- You must meet at least one melanoma risk factor, such as a past melanoma, many moles, or a family history of melanoma.
- You must be able to stand without support for about 30 minutes.
- Your height must be between 150 cm and 195 cm (about 4'11" to 6'5").
- You cannot have a cardiac pacemaker or severe claustrophobia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device that takes a close-up picture of a suspicious mole to estimate how deep the melanoma is before surgery. This might help doctors plan surgery more accurately.
This study is testing a handheld device that scans skin lesions to help detect melanoma. If you have a spot that your doctor thinks could be melanoma, this study will see how well the device works compared to standard checks.
This study is testing a new, very detailed skin imaging method (super-high magnification dermoscopy) to see if it helps doctors diagnose skin tumors more accurately during routine mole checks. If you are already coming for a skin screening, this might help improve how skin cancers are found.
This study is testing a computer program that uses photos of your moles to help doctors find skin cancer (melanoma) earlier. If you have many moles, joining could help improve this technology for everyone.
This trial tests a video-based tumor board where doctors discuss difficult skin cancer cases. It aims to help patients who are being treated outside the main cancer center get expert advice.
This trial studies whether adding or adjusting imaging scans during follow-up after melanoma surgery can help detect recurrence earlier. It compares different follow-up imaging schedules for people at higher risk after surgery.
Hear when a new Melanoma (Skin Cancer) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.